Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Merck Zocor

Executive Summary

Merck Zocor: Liver function testing for patients on simvastatin now recommended at start of therapy and periodically (such as semi-annually) for first year of therapy. FDA approved the revised recommendations May 23. Bristol-Myers Squibb received clearance in April to remove the recommendation in labeling for Pravachol for testing at six weeks and for semi-annual testing in patients with normal results at 12 weeks ("The Pink Sheet" April 28, In Brief)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030327

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel